Gibson Christopher reported conversion involving 40,000 shares of RECURSION PHARMACEUTICALS, INC. at $0.00 for $0 on Jun 5, 2026

Conversion
Form 4 code C. Conversion of a derivative security.
Director
DIR
Filed Jun 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
40,000Class A Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
923,735Direct
Trade date
Jun 5, 2026Conversion
Filed
Jun 5, 2026, 5:03 PM ET0-day reporting delay
Accession
0001856369-26-000023Code C · Transaction 100190
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jun 5, 2026Sell40,000$3.62−$144,800Trade 100191
Jun 5, 2026Conversion40,000$0.00$0Trade 100192
3 transaction rows in this filing. Joint filers share the same rows.

RXRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RXRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.6%1w ago +8.5%1d ago +15%
Returns since7d −4.8%30d +15%90d180d1y

Footnotes in full

F1: Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock. F2: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. F3: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F4: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. F5: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. F6: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. F7: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. F8: The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. F9: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. F10: The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. F11: The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.